Doctor Jocelyn Inamo
University Hospital of Fort de France, Fort de France (Martinique)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Demographic characteristics and clinical follow-up of the 2788 transthyretin amyloid cardiomyopathy patients treated with tafamidis during the French Early Access Program (RTU)
Event: Heart Failure 2023
Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease
Session: Cardiac amyloidosis from epidemiology to treatment
ESC 365 is supported by
